Publications by authors named "Lars R Perk"

Claim this Profile
O
Optimised GMP-compliant production of [F]DPA-714 on the Trasis AllinOne module.
Klaudia A Cybulska, Vera Bloemers, Lars R Perk, Peter Laverman

EJNMMI Radiopharm Chem· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production of novel diagnostic radionuclides in small medical cyclotrons.
Mateusz Adam Synowiecki, Lars Rutger Perk, J Frank W Nijsen

EJNMMI Radiopharm Chem· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(11) C-labeled and (18) F-labeled PET ligands for subtype-specific imaging of histamine receptors in the brain.
Uta Funke, Danielle J Vugts, Bieneke Janssen, Arnold Spaans, Perry S Kruijer, Lars R Perk

J Labelled Comp Radiopharm· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and initial preclinical evaluation of the P2X7 receptor antagonist [¹¹C]A-740003 as a novel tracer of neuroinflammation.
Bieneke Janssen, Danielle J Vugts, Uta Funke, Arnold Spaans, Robert C Schuit, Lars R Perk

J Labelled Comp Radiopharm· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technical note: building a combined cyclotron and MRI facility: implications for interference.
Mark B M Hofman, Joost P A Kuijer, Jan Willem de Ridder, Lars R Perk, Rudolf M Verdaasdonk

Med Phys· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Facile labelling of an anti-epidermal growth factor receptor Nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PET.
Maria J W D Vosjan, Lars R Perk, Rob C Roovers, Gerard W M Visser, Marijke Stigter-van Walsum

Eur J Nucl Med Mol Imaging· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine.
Maria J W D Vosjan, Lars R Perk, Gerard W M Visser, Marianne Budde, Paul Jurek

Nat Protoc· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging.
Lars R Perk, Maria J W D Vosjan, Gerard W M Visser, Marianne Budde, Paul Jurek

Eur J Nucl Med Mol Imaging· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(124)I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131)I-L19-SIP radioimmunotherapy.
Bernard M Tijink, Lars R Perk, Marianne Budde, Marijke Stigter-van Walsum, Gerard W M Visser

Eur J Nucl Med Mol Imaging· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging.
Eli C F Dijkers, Jos G W Kosterink, Anna P Rademaker, Lars R Perk, Guus A M S van Dongen

J Nucl Med· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30.
Lars R Perk, Marijke Stigter-van Walsum, Gerard W M Visser, Reina W Kloet, Maria J W D Vosjan

Eur J Nucl Med Mol Imaging· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immuno-PET: a navigator in monoclonal antibody development and applications.
Guus A M S van Dongen, Gerard W M Visser, Marjolijn N Lub-de Hooge, Elisabeth G de Vries, Lars R Perk

Oncologist· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft.
Wouter B Nagengast, Elisabeth G de Vries, Geke A Hospers, Nanno H Mulder, Johan R de Jong, Lars R Perk

J Nucl Med· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioimmunotherapy for indolent B-cell non-Hodgkin lymphoma in relapsed, refractory and transformed disease.
Otto J Visser, Lars R Perk, Josée M Zijlstra, Guus A M S van Dongen, Peter C Huijgens

BioDrugs· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation and evaluation of (89)Zr-Zevalin for monitoring of (90)Y-Zevalin biodistribution with positron emission tomography.
Lars R Perk, Otto J Visser, M Stigter-van Walsum, Maria J W D Vosjan, Gerard W M Visser

Eur J Nucl Med Mol Imaging· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.
Lars R Perk, Gerard W M Visser, Maria J W D Vosjan, Marijke Stigter-van Walsum, Bernard M Tijink

J Nucl Med· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis